These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 6178696)

  • 41. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
    Matzkin H; Greenstein A; Kaver I; Braf Z
    Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Various immunohistochemical markers of precancer and variants of prostate cancer].
    Romanenko AM; Vorob'eva LR
    Arkh Patol; 1995; 57(4):38-41. PubMed ID: 8526754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prostatic specific antigen in the serum in prostatic cancer].
    Fuse H; Akakura K; Akimoto S; Shimazaki J
    Hinyokika Kiyo; 1987 Jul; 33(7):1049-53. PubMed ID: 2446484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is prostate-specific antigen the most useful marker for screening in prostate cancer?
    Delaere KP; Van Dieijen-Visser MP; Gijzen AH; Brombacher PJ
    Am J Clin Oncol; 1988; 11 Suppl 2():S65-7. PubMed ID: 2468276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
    Nakano S
    Hinyokika Kiyo; 1969 Aug; 15(8):565-75. PubMed ID: 4186705
    [No Abstract]   [Full Text] [Related]  

  • 48. Economics of screening for carcinoma of the prostate.
    Optenberg SA; Thompson IM
    Urol Clin North Am; 1990 Nov; 17(4):719-37. PubMed ID: 1699340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunologic sperm detection].
    Müller V; Hinkelmann G
    Arch Kriminol; 1991; 188(3-4):106-9. PubMed ID: 1722088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Purification and determination of human prostate specific antigen in the serum].
    Ogawa Y; Morikawa J; Ohsawa R; Machida T; Miki M; Yanagisawa M
    Radioisotopes; 1984 May; 33(5):273-8. PubMed ID: 6206524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Are serum acid phosphatase levels of diagnostic significance in prostatic cancer? (author's transl)].
    Bollack C; Helwig JJ; Offner M
    Sem Hop; 1979 Dec 18-25; 55(43-44):2022-6. PubMed ID: 233445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum prostatic acid phosphatase].
    Chen M; Gai M; Fishelovitz J; Hegesh E
    Harefuah; 1983 May; 104(9):378-80. PubMed ID: 6674043
    [No Abstract]   [Full Text] [Related]  

  • 54. [An immunohistochemical study of prostate antigen using an enzyme-labeled antibody technique].
    Okano M; Deguchi T; Takeuchi T; Kuriyama M; Nishiura T
    Hinyokika Kiyo; 1983 Oct; 29(10):1369-71. PubMed ID: 6085712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

  • 56. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW; Schmiedt E
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
    McNeel DG; Nguyen LD; Ellis WJ; Higano CS; Lange PH; Disis ML
    Prostate; 2001 May; 47(3):222-9. PubMed ID: 11351352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
    Griffiths J; Rippe DF; Panfili PR
    Clin Chem; 1982 Jan; 28(1):183-6. PubMed ID: 7055908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.